Archives

The University of Tennessee Medical Center is proud to announce that the Huntington’s Disease Society of America (HDSA) and its Center Programs and Education Advisory Committee (CPEAC), has [...]

Oncotype DX is a commercially available 21-gene breast cancer test that predicts the 10-year likelihood of breast cancer recurrence for patients treated with tamoxifen. It also helps determine [...]